Influence of the novel non-sulfhydryl converting enzyme-inhibitor, Hoe-498, on isolated rat hearts. 1984

J Z Xiang, and B A Schölkens, and W Linz, and T Unger

UI MeSH Term Description Entries
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D001920 Bradykinin A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,Bradykinin Acetate, (9-D-Arg)-Isomer,Bradykinin Diacetate,Bradykinin Hydrochloride,Bradykinin Triacetate,Bradykinin, (1-D-Arg)-Isomer,Bradykinin, (2-D-Pro)-Isomer,Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (2-D-Pro-7-D-Pro)-Isomer,Bradykinin, (3-D-Pro)-Isomer,Bradykinin, (3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (5-D-Phe)-Isomer,Bradykinin, (5-D-Phe-8-D-Phe)-Isomer,Bradykinin, (6-D-Ser)-Isomer,Bradykinin, (7-D-Pro)-Isomer,Bradykinin, (8-D-Phe)-Isomer,Bradykinin, (9-D-Arg)-Isomer,Arg Pro Pro Gly Phe Ser Pro Phe Arg
D001952 Bridged-Ring Compounds Cyclic hydrocarbons that contain multiple rings which share one or more bridgehead connections. Bridged Compounds,Bridged Ring Compounds
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D005260 Female Females
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000803 Angiotensin I A decapeptide that is cleaved from precursor angiotensinogen by RENIN. Angiotensin I has limited biological activity. It is converted to angiotensin II, a potent vasoconstrictor, after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001643 Bridged Bicyclo Compounds Saturated alicyclic hydrocarbon molecules consisting of two rings that have two non-adjacent atoms in common. Bicyclo Compounds,Bicyclo Compounds, Bridged

Related Publications

J Z Xiang, and B A Schölkens, and W Linz, and T Unger
January 1985, Journal of cardiovascular pharmacology,
J Z Xiang, and B A Schölkens, and W Linz, and T Unger
January 1984, European journal of clinical pharmacology,
J Z Xiang, and B A Schölkens, and W Linz, and T Unger
March 1985, Naunyn-Schmiedeberg's archives of pharmacology,
J Z Xiang, and B A Schölkens, and W Linz, and T Unger
March 1985, Lancet (London, England),
J Z Xiang, and B A Schölkens, and W Linz, and T Unger
January 1986, European journal of clinical pharmacology,
J Z Xiang, and B A Schölkens, and W Linz, and T Unger
January 1986, Clinical and experimental hypertension. Part A, Theory and practice,
J Z Xiang, and B A Schölkens, and W Linz, and T Unger
December 1985, Archives internationales de pharmacodynamie et de therapie,
J Z Xiang, and B A Schölkens, and W Linz, and T Unger
April 1987, The American journal of cardiology,
Copied contents to your clipboard!